Moleculin Biotech, Inc.
MBRX
$0.77
$0.011.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 40.56% | -182.59% | 144.39% | -96.73% | -201.64% |
| Total Depreciation and Amortization | 0.00% | -11.11% | -59.09% | -21.43% | -9.68% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -94.73% | 124.53% | -177.35% | 135.25% | 1,978.61% |
| Change in Net Operating Assets | -40.32% | -39.81% | 210.86% | -405.97% | -147.45% |
| Cash from Operations | -8.93% | -13.88% | 25.71% | -29.40% | -22.30% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -52.54% | 1.56% | 17.57% | 17.55% | -32.20% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -52.54% | 1.67% | 17.44% | 17.55% | -32.20% |
| Foreign Exchange rate Adjustments | 82.26% | -214.81% | 1,000.00% | -- | -100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -312.30% | -33.84% | 354.68% | -437.11% | -104.62% |